Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells

Clinical trial NCT03690011 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03690011
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia

Start date: 2021-08-02
Primary completion: 2026-03-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.